National Center / Exceedingly complex / Ningbo University / University of Chicago / University of Chicago Cancer Center Support Grant / The Affiliated Hospital / Affiliated Hospital / harbor HERYVMA / /
IndustryTerm
clinical applications / cellular systems / immediate clinical applications / cancer therapy / cancer treatment / cell regulatory systems / therapies for various cancers / treatment of colorectal cancer / /
MedicalCondition
rat sarcoma / colorectal cancer / Kirsten rat sarcoma viral oncogene / TKI-sensitive lung cancer / small cell lung cancer / KRAS-mutant colorectal cancer / small-cell lung cancer / Kirsten rat sarcoma / head and neck cancer / fibrosarcoma / MS / certain colon cancer / lung cancers / cancers / NSCLC whose tumors / adenocarcinomas / Cancer / tumors / NSCLC / carcinogenesis / tumour / metastatic colorectal cancer / Jemal A. Cancer / lung cancer / continued disease / /
MedicalTreatment
chemotherapy / cancer therapy / bypass / /
Organization
National Institute of Health / PI3K / Ningbo University / Ningbo / United States Food and Drug Administration / School of Medicine / Department of Medicine / the University of Chicago / University of Chicago / National Center for Advancing Translational Sciences / University of Chicago Cancer Center Support Grant / Affiliated Hospital / Nash P. Assembly / EGFR / Biological Sciences Division / thus focused on targeting EGFR / /
Person
Abstract Commonly / Molina JR / Rossi A. Cetuximab / T. Tyrosine / Ann Oncol / Mark Applebaum / /
Position
driver / Eastwood MP / author / Hunter / cancer and human head / /
Pharmacogenomics of EGFR-targeted therapies in nonŁsmall cell lung cancer: EGFR and beyond